Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Glioblastoma 4Glioma 3Brain Neoplasms 3Neuroblastoma 2Astrocytoma 2Testicular Neoplasms 1Teratoma 1Spinal Cord Neoplasms 1Sarcoma 1Paraganglioma, Extra-Adrenal 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neurofibroma 1Neoplasms 1Meningioma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Medullary 1

Interventions

Peripheral Blood Stem Cell Transplantation 7Filgrastim 7Carboplatin 7Ifosfamide 6Etoposide 6Radiotherapy 4Thiotepa 3Paclitaxel 3Cisplatin 3liposomal amphotericin B 2ixabepilone 2etoposide phosphate 2Therapeutics 2Temozolomide 2Psychiatric Rehabilitation 2Neoadjuvant Therapy 2Cyclophosphamide 2Bleomycin 2sodium thiosulfate 1sargramostim 1pegfilgrastim 1aldesleukin 1Ribavirin 1Restraint, Physical 1Palivizumab 1PT-100 dipeptide 1Oxaliplatin 1O(6)-benzylguanine 1Microarray Analysis 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Teratoma × Restraint, Physical × CNS × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡